You just read:

Samus Therapeutics Announces Launch of Expanded Clinical Development Programs for Novel Anti-Epichaperome Small Molecules to Diagnose and Treat Cancer and Neurodegenerative Disease

News provided by

Samus Therapeutics

Mar 30, 2017, 10:00 ET